2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Pocket Pal
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Denis E. Bragin, Ph.D., FAHA (he/him/his)

Lovelace Biomedical, New Mexico

Denis E. Bragin, Ph.D., FAHA, FCCM, is an Associate Professor of Translational Neuroscience at the Lovelace Biomedical Research Institute, with adjunct appointments in the Department of Neurology at the University of New Mexico Health Sciences Center School of Medicine and the Department of Cell and Molecular Physiology at New York Medical College. A recognized leader in the field, Dr. Bragin is a Fellow of the American Heart Association (Stroke Council) and a Fellow of Critical Care Medicine. He currently serves as a Board Director for the International Society for Cerebral Blood Flow and Metabolism and is an active member of the American Heart Association, the International Society on Oxygen Transport to Tissue, the Society of Photo-Optical Instrumentation Engineers, and the Society of Critical Care Medicine.
Dr. Bragin has authored over 100 peer-reviewed publications, delivered more than 100 international presentations, and holds 6 U.S. and international patents. His research has been consistently supported by multimillion-dollar grants from the National Institutes of Health (NIH), the Department of Defense (DOD), and the American Heart Association. He currently serves as the Principal Investigator on a DOD CDMRP grant to develop advanced resuscitation fluids for polytrauma.
His research focuses on brain circulation and metabolism following traumatic brain injury (TBI), stroke, and cerebrovascular diseases. Key research interests include:
• The role of cerebral microvascular shunting in the development of hyperemia, edema, and blood-brain barrier degradation during intracranial hypertension.
• Hemodynamic modulation using drag-reducing polymers (DRP) to treat acute and chronic microvascular disorders, including stroke, TBI, sepsis, and neurodegenerative diseases.
• Non-invasive neuromodulation, including transcranial photobiomodulation, pulsed electromagnetic fields, and vagus nerve stimulation, to accelerate recovery after acute brain injuries and improve glymphatic clearance.

Presentation(s):